Ethnic differences in ApoC-III concentration and the risk of cardiovascular disease: No evidence for the cardioprotective role of rare/loss of function APOC3 variants in non-Europeans

American Heart Journal Plus: Cardiology Research and Practice(2022)

引用 1|浏览3
暂无评分
摘要
These results highlight the challenges of generalizing antisense ApoC-III inhibition for treating atherosclerotic disease in dyslipidemia that may benefit only specific sub-populations. The observed ethnic differences in ApoC-III concentrations and CAD risk factors, emphasize in-depth genetic and metabolomics evaluations on diverse ancestries.
更多
查看译文
关键词
Circulating triglycerides,Apolipoprotein C-III concentration,Lipid metabolites,Rare variants,Ethnicity,Cardiovascular disease
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要